fbpx
Connect with us

News

Scottish health tech firm Emblation strikes German deal

Published

on

Emblation founders

A Scottish health tech company has launched in Europe’s biggest healthcare market after striking a deal with a leading German medical device company.

The Swift device, manufactured by Alloa-based firm Emblation, uses microwave technology to treat common podiatry problems.

Swift enables medical professionals to resolve persistent common and plantar warts (verrucae) with a simple microwave treatment.

An eight-figure investment will see Emblation expand rapidly across the continent, with Swift devices available in German and Austrian clinics.

Emblation will be working with Munich-based Medaesthetis GmbH, a specialist in medical devices across Aesthetics, Dermatology, Ophthalmology and Orthopaedics.

Emblation co-founder and CEO, Gary Beale, said:

“Up until now we have been planning our presence in mainland Europe and our recent investment was all about changing that, so we are extremely pleased to be making such rapid progress.

“Working with a distributor of the quality and reputation of Medaesthetis is the perfect launchpad.

“We’ve been impressed with every aspect of how they operate their business and the team’s knowledge, passion and, most importantly of all, encyclopaedic knowledge of our target sectors.”

The firm is also growing its research and development capability to build on promising early results which could result in breakthroughs in the treatment of skin cancers and pre-cancers.

Medaesthetis head of marketing and sales, Hardy Weiss, said:

“In the field of medical devices, the term innovation is often over inflated. With Emblation’s Swift microwave technology, doctors and patients in Germany and Austria will now have access to a real and genuine innovation.

“The repeatability of treating benign skin lesions in only a few seconds will deliver predictable outcomes with a high safety profile.”

Major new distribution deals, clinical partnerships and other opportunities are going to plan across Benelux, France, Switzerland and Greece as well as further afield including Israel and UAE, the company said.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending stories